Algernon Pharmaceuticals Inc (AGN.CX)
0.085
0.00 (0.00%)
CAD |
CNSX |
Nov 12, 14:04
Algernon Pharmaceuticals Total Liabilities (Quarterly): 2.237M for Nov. 30, 2022
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| November 30, 2022 | 2.237M |
| August 31, 2022 | 2.516M |
| May 31, 2022 | 1.348M |
| February 28, 2022 | 1.441M |
| November 30, 2021 | 0.6249M |
| August 31, 2021 | 1.022M |
| May 31, 2021 | 1.900M |
| February 28, 2021 | 1.576M |
| November 30, 2020 | 1.129M |
| August 31, 2020 | 0.6071M |
| May 31, 2020 | 1.110M |
| February 29, 2020 | 0.237M |
| November 30, 2019 | 0.3321M |
| August 31, 2019 | 0.3655M |
| May 31, 2019 | 0.2331M |
| Date | Value |
|---|---|
| February 28, 2019 | 0.1421M |
| November 30, 2018 | 0.2432M |
| August 31, 2018 | 0.057M |
| May 31, 2018 | 0.0099M |
| February 28, 2018 | 0.0344M |
| November 30, 2017 | 0.0416M |
| August 31, 2017 | 0.0478M |
| May 31, 2017 | 0.0303M |
| February 28, 2017 | 0.0952M |
| November 30, 2016 | 0.1645M |
| August 31, 2016 | 0.1504M |
| May 31, 2016 | 0.0637M |
| February 29, 2016 | 0.0635M |
| November 30, 2015 | 0.1269M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.237M
Minimum
Feb 2020
2.516M
Maximum
Aug 2022
1.237M
Average
1.129M
Median
Nov 2020
Total Liabilities (Quarterly) Benchmarks
| Biocure Technology Inc | 0.44M |
| Core One Labs Inc | 1.759M |
| Restart Life Sciences Corp | 1.072M |
| Nanosphere Health Sciences Inc | 2.276M |
| Lobe Sciences Ltd | 3.073M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.674M |
| Shareholders Equity (Quarterly) | 4.436M |